Assoc. Prof. Dr. Vahid Eslami, Shahid Modarres hospital, Iran
Assoc. Prof. Dr. Vahid Eslami is a board-certified Interventional Cardiologist and Structural Heart Specialist based in Tehran, Iran. With over 14 years of experience, he specializes in high-risk coronary interventions, TAVI, CTO angioplasty, and advanced cardiac imaging (IVUS, OCT). 🏥 As Head of the Cardiovascular Department at Shahid Beheshti University, he leads clinical education and research, boasting 50+ peer-reviewed publications and an H-index of 11. 🎓 A Fellow of the American College of Cardiology and member of ESC, EAPCI, and ISOIC, Dr. Eslami actively mentors cardiology trainees and presents at global cardiology congresses.
Publication Profile
Google Scholar
Professional Experience
Assoc. Prof. Dr. Vahid Eslami is a distinguished Interventional Cardiologist and Head of the Cardiovascular Department at Shahid Beheshti Medical University, Tehran. With over a decade of clinical and academic excellence, he has led multidisciplinary teams, performed over 500 complex coronary interventions, and implemented advanced imaging technologies like IVUS and OCT. 📈 He has overseen impactful research, contributing to 20+ high-impact publications and international conference presentations. 🏥 As a medical educator, he has trained over 100 cardiology residents and fellows. 🧑⚕️ A respected leader and national board member for myocardial infarction treatment, he actively shapes Iran’s cardiovascular protocols. 🌍
🎓 Education & Medical Training
Dr. Vahid Eslami completed his Doctor of Medicine (MD) at Tehran University of Medical Sciences (1999–2006), ranking 11th among 300,000 applicants in the national entrance exam. 🏅 He pursued a Cardiology Residency (2006–2010) at Shahid Beheshti University of Medical Sciences, where his thesis on QT dispersion post-primary PCI was published in a U.S. journal. 🫀 He then completed a Fellowship in Interventional Cardiology (2012–2014) at the same university, focusing on coronary angiography and FFR, with his research again featured in international journals. 📘 His training solidified his expertise in advanced cardiovascular care and research
🏅 Licenses & Certifications
Dr. Vahid Eslami is a board-certified Interventional Cardiologist, accredited by the American College of Cardiology (ACC) 🎓. He holds active memberships in several esteemed cardiology organizations, including the American College of Cardiology , the European Association of Percutaneous Cardiovascular Interventions (EAPCI) , and the Iranian Society of Interventional Cardiology (ISOIC) . These affiliations reflect his global engagement and adherence to the highest standards of cardiovascular care.His certifications and memberships support his ongoing contributions to research, education, and innovation in interventional cardiology.
🧠🔬 Research Focus
Assoc. Prof. Dr. Vahid Eslami’s research is deeply rooted in interventional cardiology, with significant contributions to COVID-19 cardiovascular outcomes , anticoagulation therapies, and ischemic heart disease. His studies focus on complex coronary interventions, QT interval dynamics, inflammatory biomarkers, and gender differences in cardiac risk. He’s actively involved in randomized controlled trials and has examined the visual-functional mismatch in coronary diagnostics. He also explores the role of epicardial fat and cardiac imaging indices in disease progression. His multidisciplinary work bridges clinical practice and cardiovascular research, advancing protocols for acute and critical care cardiology
Publication Top Notes
-
📄 Effect of intermediate-dose vs standard-dose prophylactic anticoagulation… – 📊738 citations | 📅2021
-
📄 Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19… – 📊87 citations | 📅2022
-
📄 Atorvastatin versus placebo in patients with covid-19 in intensive care… – 📊76 citations | 📅2022
-
📄 Evaluation of QT, QT dispersion, and T-wave peak to end time changes… – 📊61 citations | 📅2013
-
📄 Association of CT-measured cardiac indices with lung involvement in COVID-19 – 📊48 citations | 📅2021
-
📄 Are women more susceptible to ischemic heart disease? A literature overview – 📊36 citations | 📅2021
-
📄 Epicardial adipose tissue, inflammatory biomarkers and COVID-19 – 📊31 citations | 📅2021
-
📄 Extrinsic compression of left main coronary artery by the pulmonary trunk… – 📊28 citations | 📅2009
-
📄 Management of STEMI during COVID-19: Iranian “247” National Committee’s position paper – 📊26 citations | 📅2021
-
📄 Prognostic value of inflammatory biomarkers in COVID-19 patients – 📊15 citations | 📅2021